Embedded Files
Uthika Laboratories Private Limited is a pharmaceutical manufacturing company specializing in premium tablets, capsules, and generic medicines. We deliver WHO-GMP compliant formulations across gastrointestinal, cardiac, anti-infective, pain management, and diabetes therapeutic areas.
Serving both domestic and export markets, our operations combine advanced manufacturing infrastructure, robust quality systems, scalable production capacity, and a commitment to sustainable, technology-driven growth.
What we do
What we do
Contract Manufacturing
Contract Manufacturing
Flexible CMD/CDMO production for pharma brands and distributors.
Export Oriented Supply
Export Oriented Supply
Production and packaging alinged to semi regulated and regulated market
Private Label Manufacturing
Private Label Manufacturing
Customized branding and product creation for retailers and hospitals.
Coustom Formulation & R&D
Coustom Formulation & R&D
End-to-end development support for complex and generic products.
Generic Medicine Producion
Generic Medicine Producion
200+ formulations across cardio, diabetic, Gl and anti-infective.
Digital B2B Procurement
Digital B2B Procurement
Makemymeds app and e-commerce platform seamless ordering.
What We Manufacture
What We Manufacture
Tablets
Tablets
Uncoated & flim-coated
Sugar-coated & chewable
Sustained-release
Effervescent & bi-layered
Capsules
Capsules
Hard-gelatin capsules
Tablet-in-capsule
Vegetarian capsules
Packaging
Packaging
Alu/Alu cold-form blister
PVC/PVDC blister packing
Strip packing
Loose pack
Solving for complex generics, not just standard batches.
Solving for complex generics, not just standard batches.
Focused on developing complex generic products with difficult-to-handle APIs — identifying and reducing impurity profiles, engineering extended-release profiles, designing new production processes, and pairing drugs with devices for high-potency, controlled-substance, and low-solubility products. In-house R&D optimizes formulation and manufacturing, runs required stability testing, and works with qualified third-party CROs for clinical studies and regulatory licensing.
Innovation is treated as an operating discipline, not a slogan. Uthika produces a complementary portfolio of specialty and generic products — including APIs and intermediates — improved through constant innovation to widen the range of treatable conditions.
One active area is microfluidics for manufacturing nanoscale drug products: precise fluidic modulation and enhanced mixing enable controlled synthesis of drug-loaded nanoparticles at low cost.
Page updated
Google Sites
Report abuse